Cargando…

ApoE Plasma Levels and Risk of Cardiovascular Mortality in Old Age

BACKGROUND: The ɛ2, ɛ3, and ɛ4 alleles of the apolipoprotein E gene (APOE) encode three isoforms, apoE2, E3, and E4, respectively. The apoE isoforms circulate in different plasma concentrations, but plasma concentrations of the same isoform also differ between individuals. Whereas the isoforms have...

Descripción completa

Detalles Bibliográficos
Autores principales: Mooijaart, Simon P, Berbée, Jimmy F. P, van Heemst, Diana, Havekes, Louis M, de Craen, Anton J. M, Slagboom, P. Eline, Rensen, Patrick C. N, Westendorp, Rudi G. J
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1457005/
https://www.ncbi.nlm.nih.gov/pubmed/16671834
http://dx.doi.org/10.1371/journal.pmed.0030176
_version_ 1782127421980409856
author Mooijaart, Simon P
Berbée, Jimmy F. P
van Heemst, Diana
Havekes, Louis M
de Craen, Anton J. M
Slagboom, P. Eline
Rensen, Patrick C. N
Westendorp, Rudi G. J
author_facet Mooijaart, Simon P
Berbée, Jimmy F. P
van Heemst, Diana
Havekes, Louis M
de Craen, Anton J. M
Slagboom, P. Eline
Rensen, Patrick C. N
Westendorp, Rudi G. J
author_sort Mooijaart, Simon P
collection PubMed
description BACKGROUND: The ɛ2, ɛ3, and ɛ4 alleles of the apolipoprotein E gene (APOE) encode three isoforms, apoE2, E3, and E4, respectively. The apoE isoforms circulate in different plasma concentrations, but plasma concentrations of the same isoform also differ between individuals. Whereas the isoforms have been associated with cardiovascular disease, the relation between plasma apoE levels and cardiovascular disease is unknown. METHODS AND FINDINGS: We assessed APOE genotypes, plasma levels of apoE, cardiovascular risk factors, and mortality in a population-based sample of 546 individuals aged 85 y who participated in the Leiden 85-plus Study and were prospectively followed for specific causes of death for 5 y. Participants in the highest tertile of apoE levels suffered a twofold-increased risk of cardiovascular mortality (hazard ratio compared to lowest tertile, 2.08; 95% confidence interval [CI], 1.30 to 3.33). Among the 324 participants with the ɛ3ɛ3 genotype, the hazard from cardiovascular disease was threefold increased (highest versus lowest tertile 3.01; 95% CI 1.60 to 5.66), with similar estimates for men and women. Other causes of death were not increased significantly. Plasma levels of apoE in ɛ3ɛ3 participants were positively correlated with total cholesterol ( p < 0.001), low-density lipoprotein cholesterol ( p < 0.001) and triglycerides ( p < 0.001) and negatively with high-density lipoprotein cholesterol levels ( p = 0.010). Adjustment for plasma lipids did not change the hazard ratios, whereas interaction was absent. The risk associated with high levels of apoE, however, was strongest in participants from the lowest tertile of C-reactive protein (CRP) levels and absent in those from the highest tertile ( p (interaction) < 0.001). Among participants from the lowest tertile of CRP levels, those with a high apoE levels had a significantly steeper increase in CRP than those with low apoE levels ( p = 0.020). Similar cardiovascular mortality risks as in ɛ3ɛ3 participants were found in ɛ2 and ɛ4 carriers. CONCLUSIONS: In old age, high plasma apoE levels precede an increase of circulating CRP and strongly associates with cardiovascular mortality, independent of APOE genotype and plasma lipids.
format Text
id pubmed-1457005
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-14570052006-06-19 ApoE Plasma Levels and Risk of Cardiovascular Mortality in Old Age Mooijaart, Simon P Berbée, Jimmy F. P van Heemst, Diana Havekes, Louis M de Craen, Anton J. M Slagboom, P. Eline Rensen, Patrick C. N Westendorp, Rudi G. J PLoS Med Research Article BACKGROUND: The ɛ2, ɛ3, and ɛ4 alleles of the apolipoprotein E gene (APOE) encode three isoforms, apoE2, E3, and E4, respectively. The apoE isoforms circulate in different plasma concentrations, but plasma concentrations of the same isoform also differ between individuals. Whereas the isoforms have been associated with cardiovascular disease, the relation between plasma apoE levels and cardiovascular disease is unknown. METHODS AND FINDINGS: We assessed APOE genotypes, plasma levels of apoE, cardiovascular risk factors, and mortality in a population-based sample of 546 individuals aged 85 y who participated in the Leiden 85-plus Study and were prospectively followed for specific causes of death for 5 y. Participants in the highest tertile of apoE levels suffered a twofold-increased risk of cardiovascular mortality (hazard ratio compared to lowest tertile, 2.08; 95% confidence interval [CI], 1.30 to 3.33). Among the 324 participants with the ɛ3ɛ3 genotype, the hazard from cardiovascular disease was threefold increased (highest versus lowest tertile 3.01; 95% CI 1.60 to 5.66), with similar estimates for men and women. Other causes of death were not increased significantly. Plasma levels of apoE in ɛ3ɛ3 participants were positively correlated with total cholesterol ( p < 0.001), low-density lipoprotein cholesterol ( p < 0.001) and triglycerides ( p < 0.001) and negatively with high-density lipoprotein cholesterol levels ( p = 0.010). Adjustment for plasma lipids did not change the hazard ratios, whereas interaction was absent. The risk associated with high levels of apoE, however, was strongest in participants from the lowest tertile of C-reactive protein (CRP) levels and absent in those from the highest tertile ( p (interaction) < 0.001). Among participants from the lowest tertile of CRP levels, those with a high apoE levels had a significantly steeper increase in CRP than those with low apoE levels ( p = 0.020). Similar cardiovascular mortality risks as in ɛ3ɛ3 participants were found in ɛ2 and ɛ4 carriers. CONCLUSIONS: In old age, high plasma apoE levels precede an increase of circulating CRP and strongly associates with cardiovascular mortality, independent of APOE genotype and plasma lipids. Public Library of Science 2006-06 2006-05-09 /pmc/articles/PMC1457005/ /pubmed/16671834 http://dx.doi.org/10.1371/journal.pmed.0030176 Text en Copyright: © 2006 Mooijaart et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Mooijaart, Simon P
Berbée, Jimmy F. P
van Heemst, Diana
Havekes, Louis M
de Craen, Anton J. M
Slagboom, P. Eline
Rensen, Patrick C. N
Westendorp, Rudi G. J
ApoE Plasma Levels and Risk of Cardiovascular Mortality in Old Age
title ApoE Plasma Levels and Risk of Cardiovascular Mortality in Old Age
title_full ApoE Plasma Levels and Risk of Cardiovascular Mortality in Old Age
title_fullStr ApoE Plasma Levels and Risk of Cardiovascular Mortality in Old Age
title_full_unstemmed ApoE Plasma Levels and Risk of Cardiovascular Mortality in Old Age
title_short ApoE Plasma Levels and Risk of Cardiovascular Mortality in Old Age
title_sort apoe plasma levels and risk of cardiovascular mortality in old age
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1457005/
https://www.ncbi.nlm.nih.gov/pubmed/16671834
http://dx.doi.org/10.1371/journal.pmed.0030176
work_keys_str_mv AT mooijaartsimonp apoeplasmalevelsandriskofcardiovascularmortalityinoldage
AT berbeejimmyfp apoeplasmalevelsandriskofcardiovascularmortalityinoldage
AT vanheemstdiana apoeplasmalevelsandriskofcardiovascularmortalityinoldage
AT havekeslouism apoeplasmalevelsandriskofcardiovascularmortalityinoldage
AT decraenantonjm apoeplasmalevelsandriskofcardiovascularmortalityinoldage
AT slagboompeline apoeplasmalevelsandriskofcardiovascularmortalityinoldage
AT rensenpatrickcn apoeplasmalevelsandriskofcardiovascularmortalityinoldage
AT westendorprudigj apoeplasmalevelsandriskofcardiovascularmortalityinoldage